Bridgewater, N.J.-based Clinical Genomics launched Colvera, a blood-based test for colorectal cancer recurrence monitoring. Here’s what you need to know. 1. Colvera is a qualitative test that ...
ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics, Inc., a clinical-stage company bridging the precision medicine gap by decoding RNA, announced today the validation and launch of OncoPrism ®-NSCLC, an ...
ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics, Inc., a clinical-stage company bridging the precision medicine gap by decoding RNA, announced the publication of their PREDAPT clinical trial ...
FORT MYERS, Fla. and FREMONT, Calif., April 29, 2025 /PRNewswire/ -- NeoGenomics, Inc. (NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, and Ultima Genomics, ...
The Alzheimer's Association released its first comprehensive clinical practice guidelines for the diagnosis, treatment, and care of Alzheimer's disease (AD) at the end of July. This landmark document ...
The UC Santa Cruz Colligan Clinical Diagnostic Laboratory (CCDL) has received its CLIA certificate of registration from the California Department of Public Health, which clears the way for it to begin ...
Zacks Investment Research on MSN
WGS, Zevra partner to launch genetic testing for Niemann-Pick type C
GeneDx Holdings WGS announced a sponsored genetic testing program with Zevra Therapeutics to improve diagnosis for patients suspected of having Niemann-Pick Disease Type C (NPC), a rare and ...
Genomics announced new multi year collaborations in cancer research with PharosAI, the Cancer Research Institute, and Dana Farber Cancer Institute. The partners plan to use 10x Genomics spatial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results